Sign in

You're signed outSign in or to get full access.

Gail E. Lehman

Executive Vice President, Chief Legal and Sustainability Officer, and Secretary at HEXCEL CORP /DE/HEXCEL CORP /DE/
Executive

About Gail E. Lehman

Gail E. Lehman, age 65, is Executive Vice President, Chief Legal and Sustainability Officer, and Corporate Secretary at Hexcel; she has been an executive officer since 2017 and transitioned from EVP, General Counsel & Secretary to her current role effective January 1, 2025 . Her career includes senior legal and administrative leadership at Noranda Aluminum (Chief Administrative Officer, General Counsel & Corporate Secretary), Hawker Beechcraft, Covalence Specialty Materials, and Honeywell’s Law Department, with Noranda having filed for bankruptcy protection on February 8, 2016 prior to her joining Hexcel . Company performance in 2024 featured sales of $1,903M (+6.4% y/y), adjusted diluted EPS of $2.03 (+12% y/y), adjusted EBIT of $237.7M, net cash from operations of $289.9M, and free cash flow of $202.9M . Over 2019–2024, the company’s TSR for a fixed $100 investment was $87.77 per pay-versus-performance disclosure (contextual board-level metric) .

Past Roles

OrganizationRoleYearsStrategic Impact
HexcelEVP, General Counsel & Secretary2017–2024Led legal, governance, and corporate secretary functions through growth and CEO transition; joined leadership team in 2017 .
HexcelEVP, Chief Legal & Sustainability Officer & Secretary2025–presentExpanded remit to sustainability oversight and board-level disclosures .
Noranda Aluminum Holding Corp.CAO, General Counsel & Corporate Secretary; VP HR, General Counsel & Corporate Secretary; VP, General Counsel & Secretary2010–2016Enterprise legal leadership; note Noranda filed Chapter 11 in 2016 (pre-Hexcel) .
Hawker Beechcraft Corp.VP, General Counsel & Corporate Secretary2007–2009Aerospace legal leadership .
Covalence Specialty Materials Corp.VP, General Counsel & Corporate Secretary2006–2007Industrial materials legal leadership .
Honeywell International Inc.Assistant General Counsel, Treasury & Finance; Assistant Secretary; other roles1993–2006Corporate finance legal and governance expertise at diversified industrial .

External Roles

No public company directorships or external board roles disclosed for Ms. Lehman in the proxy .

Fixed Compensation

Multi-year realized and reported pay:

Metric (USD)202220232024
Salary$482,843 $499,743 $517,234
Bonus
Stock Awards (RSUs/PSAs grant-date fair value)$467,704 $599,574 $620,627
Option Awards (grant-date fair value)$280,597 $199,895 $206,877
Non-Equity Incentive (MICP)$338,087 $467,759 $461,993
All Other Compensation$60,232 $81,578 $87,151
Total$1,629,463 $1,848,549 $1,893,882

All Other Compensation detail (2024):

  • Company 401(k) contributions $23,375; NDCP company contributions $53,387; premiums for life/LTD/AD&D insurance $10,389 .

Deferred compensation participation (2024):

  • Executive NDCP contributions $55,509; company NDCP contributions $53,387; aggregate NDCP balance year-end $487,759 .

Ownership guidelines:

  • Executive Vice Presidents: 3x base salary; as of December 31, 2024 all named executive officers met or were complying with retention ratios under the policy .

Performance Compensation

Annual cash incentives (MICP – company-wide financial metrics):

MetricWeightThresholdTargetMaxActualPayout vs Target
Free Cash Flow50%$230.8M $288.5M $346.2M $332.9M 176.9%
Adjusted EBIT50%$208.2M $260.3M $312.4M $237.7M 78.3%
Weighted Average Achievement127.6%

2024 individual target opportunity and payout (Lehman):

MeasureTarget AwardActual Award
2024 MICP (70% of salary; target % increased from 65%→70% y/y)$362,063 $461,993

Long-term equity incentives (annual grant cycle and design):

  • 2024 PSAs: ROIC% (50%) and Relative EPS Growth vs S&P MidCap 400 (50%), 3-year performance period (2024–2026), payout 50%–200% of target; dividend equivalents paid if and when PSAs vest for U.S. participants .
  • 2024 NQOs: time-based vesting 1/3 on each of the first three anniversaries; exercise price equals grant-date close; strike $66.77 for annual cycle grants (Lehman) .
  • 2024 RSUs: time-based vesting 1/3 on each of the first three anniversaries (U.S. execs) .

2024 grants (Lehman):

AwardGrant DateQuantityTermsGrant-Date Basis
PSAs (target)01/29/2024 6,197 ROIC% and Relative EPS Growth; 3-year; 50–200% payout Close price on grant date (ASC 718)
RSUs01/29/2024 3,098 1/3 vest at 12/24/36 months; dividend equivalents for U.S. Close price on grant date (ASC 718)
NQOs01/29/2024 8,524 1/3 vest annually; 10-year term Strike $66.77

Performance realization of prior PSAs (2012–2024 cycle awarded in 2022; paid Jan 2025):

PSA ComponentWeightOutcomeLehman Shares IssuedCash Dividends Paid
ROIC%25%70.7% payout (ROIC 9.3%)
Relative EPS Growth vs S&P MidCap 40025%200% payout (≥75th percentile)
Incremental Adjusted EBIT Leverage (2022/2023/2024)50%14.3% weighted average payout (0% in 2023 & 2024)
Weighted Average PSA Payout82.0% 4,410 shares (target 5,379) $6,616

Equity Ownership & Alignment

Beneficial ownership and guideline compliance:

  • Shares beneficially owned: 93,021; includes 76,128 underlying vested/deferred RSUs/NQOs counted for beneficial ownership; none pledged .
  • Shares outstanding: 80,389,391 as of March 13, 2025 .
  • Ownership as % of outstanding: ~0.12% (93,021 / 80,389,391) .

Outstanding awards as of Dec 31, 2024 (Lehman):

CategoryCountNotable Terms
Options exercisable8,829 (2018); 10,441 (2019); 10,855 (2020); 25,078 (2021) Mix of strikes: $68.15 (2018), $65.56 (2019), $74.74 (2020), $44.90 (2021); 10-year expirations .
Options unexercisable4,370 (2022); 4,970 (2023); 8,524 (2024) Time-based vesting; strikes $52.17 (2022), $68.79 (2023), $66.77 (2024) .
RSUs unvested1,195 (2022); 1,936 (2023); 3,098 (2024) U.S. vesting 1/3 annually; dividends accrue and pay on vest .
PSAs unearned (target)5,811 (2023); 6,197 (2024) 3-year performance; payout 0–200% .

Alignment policies and pressure indicators:

  • Prohibitions: hedging/short sales/pledging; pre-clearance required for insiders .
  • Stock ownership guidelines: EVP at 3× salary; all named executives in compliance/retention ratio as of 12/31/2024 .
  • In-the-money options vs $62.70 close (12/31/2024): 2021 ($44.90) and 2022 ($52.17) grants are ITM; 2018/2019/2023/2024 strikes above close are OTM; one 2020 grant at $74.74 OTM .

Employment Terms

Severance and change-in-control economics (Lehman):

ProvisionNon-CIC Termination (involuntary or good reason)CIC/Potential CIC Termination
Cash severance1.0× (base salary + 3-year average MICP) 2.0× (base salary + 3-year average MICP)
Benefits continuation12 months 24 months
Pro-rata MICP for year of terminationYes (if payable under plan) Yes (if payable under plan)
Non-compete12 months post-term (24 months if CIC) 24 months
Agreement termAuto-renews annually unless notice; Gentile’s agreement is at-will without term (context) .Same renewal construct

Equity award treatment:

  • Single-trigger equity vesting upon change-in-control: all RSUs convert; options vest; PSAs pay at target immediately; further option exercise windows apply if terminated within 2 years post-CIC .
  • Retirement/disability/death treatments specified: RSUs continue vesting on schedule for eligible retirement/disability; options vest/extend; PSAs pro-rata (non-cause term) .

Clawbacks and risk controls:

  • Mandatory clawback (restatement-related; last 3 years) and discretionary clawback for misconduct/material errors/failure to manage risk; equity awards include additional clawback tied to non-compete/confidentiality .

Investment Implications

  • Pay-for-performance alignment: Lehman’s 2024 variable compensation reflected a 127.6% weighted payout driven by strong free cash flow but below-target adjusted EBIT, consistent with the MICP design emphasizing FCF and EBIT; her target MICP was increased to 70% of salary in 2024, raising performance sensitivity .
  • Retention risk and selling pressure: Large balances of unvested RSUs/PSAs and unexercisable options (notably 2023–2024 grants) indicate retention hooks; however, single-trigger equity vesting at change-in-control could accelerate supply (vest-and-sell) in M&A scenarios .
  • Alignment strength: No pledging or hedging permitted and compliance with 3x salary ownership guideline reduces misalignment risk; beneficial ownership of 93,021 shares supports skin-in-the-game though absolute % of float is small (~0.12%) .
  • Governance quality signals: High say-on-pay support (~94%) and independent compensation consultant (Semler Brossy) with no conflicts suggest stable shareholder alignment in pay design; no excise tax gross-ups and no option repricing without shareholder approval further de-risk pay practices .

Compensation Structure Details (reference)

  • Annual LTI mix (non-CEO): PSAs (50%), RSUs (25%), NQOs (25%); CEO receives PSAs and NQOs only (no RSUs); PSAs target ROIC and relative EPS growth .
  • Equity grant timing policy: Annual grants on 3rd full trading day post year-end earnings; off-cycle timing governed by policy; options priced at close; RSUs/PSAs valued at close, ASC 718 .

Compensation Peer Group and Say-on-Pay

  • Peer group used for 2024 decisions: AAR Corp., Albemarle, AMETEK, Barnes Group, Cabot, Crane, Curtiss-Wright, H.B. Fuller, ITT, Moog, Spirit AeroSystems, Teledyne, Triumph Group, Woodward .
  • 2024 Say-on-Pay approval: ~94% of votes cast supported NEO compensation; no program changes deemed necessary .

Compensation Committee & Consultants

  • Compensation Committee members: Chair Guy C. Hachey; members James J. Cannon, Thomas A. Gendron (until May 8, 2025), Catherine A. Suever; independence affirmed .
  • Consultant: Semler Brossy engaged; independence assessed—no conflicts; supports market benchmarking and incentive design .

Risk Indicators & Red Flags

  • Single-trigger equity vesting at CIC (equity immediate vesting/payout) increases potential accelerated liquidity events; severance cash multiples use double-trigger, mitigating some risks .
  • Prohibitions and policies: no hedging/pledging/short sales; no option repricing without shareholder approval; no excise tax gross-ups under severance policy; robust clawbacks .

Equity Ownership Summary (as of 3/13/2025)

ItemValue
Beneficially owned shares93,021
Ownership % of outstanding~0.12% (93,021 / 80,389,391)
None pledgedYes
RSUs unvested (by grant year)1,195 (2022); 1,936 (2023); 3,098 (2024)
PSAs target outstanding5,811 (2023); 6,197 (2024)
Options exercisable (select grants)8,829 (2018); 10,441 (2019); 10,855 (2020); 25,078 (2021)
Options unexercisable (select grants)4,370 (2022); 4,970 (2023); 8,524 (2024)

Employment Terms Summary

FeatureDetail
Agreement renewalAuto-renew annually unless company notice (Lehman)
Non-compete12 months post-term; 24 months if CIC
Severance cash1.0× salary+3-year avg MICP (non-CIC); 2.0× under CIC/potential CIC
Benefits continuation12 months (non-CIC); 24 months (CIC)
Equity at CICSingle-trigger vest/convert; PSAs pay at target; options vest; extended exercise post-CIC termination
ClawbacksMandatory (restatement) and discretionary (misconduct/material errors/risk failures); equity clawback for covenant breaches

Investment Implications

  • Elevated at-risk pay and tightened ownership requirements support alignment; 2024 payout skewed towards FCF outperformance with EBIT under target suggests balanced discipline in incentive outcomes .
  • Retention appears strong given material unvested RSUs/PSAs and unexercisable options; monitor for single-trigger equity acceleration risk in strategic transactions .
  • Governance and shareholder posture favorable (94% Say-on-Pay; no repricing; clawbacks; consultant independence), reducing policy-related risk to valuation and event-driven dislocations .